[Pharmacological therapy of disseminated intravascular coagulation (DIC); State and developmental trends].
D000818:Animals; D000991:Antithrombins / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D002066:Busulfan / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy*; D004876:Ergot Alkaloids / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D051381:Rats; D012911:Snakes; D014688:Venoms / Q000627:therapeutic use; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000991:Antithrombins; D004876:Ergot Alkaloids; D005343:Fibrinolytic Agents; D014688:Venoms; D014812:Vitamin K; D002066:Busulfan
Pharmakologische Beeinflussung der disseminierten intravaskulären Gerinnung (DIC) - Stand und Entwicklungstendenzen.